Acarbose and Atacand drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acarbose (acarbose) and Atacand (candesartan cilexetil). Common drug interactions include blood creatinine increased among females and aspartate aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Acarbose and Atacand. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Acarbose?

Acarbose has active ingredients of acarbose. It is often used in diabetes. eHealthMe is studying from 4,605 Acarbose users. Check the latest studies of Acarbose.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

On Jul, 06, 2026

25 people who take Acarbose and Atacand together, and have interactions are studied.

What are the common drug interactions of Acarbose and Atacand, by gender? *:

female:

Blood creatinine increased
Cardiac failure
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Renal failure acute (rapid kidney dysfunction)
Coagulation time prolonged
Eosinophilia (eosinophil count in the peripheral blood exceeds)
Anuria (failure of the kidneys to produce urine)
Blood sodium increased
Diabetic nephropathy (diabetic kidney disease)
Electrolyte imbalance

male:

Aspartate aminotransferase increased
Blood alkaline phosphatase nos increased
Cerebellar infarction (impaired blood circulation to cerebellum)
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Dysarthria (speech disorder)
Hypokalaemia (low potassium)
Mitral valve incompetence (inefficient heart valve)
Pseudoaldosteronism (medical condition that mimics hyperaldosteronism, it produces hypertension associated with low plasma renin activity, and metabolic alkalosis associated with hypokalemia)
Rash macular (small, flat red spots)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

What are the common drug interactions of Acarbose and Atacand, by age (0-1 to 60+)? *:

0-1:

Melaena (the passage of black, tarry stools)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Blood creatinine increased
Blood urea increased
Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
Fall
Hyperkalaemia (damage to or disease of the kidney)
Renal failure (kidney dysfunction)

40-49:

Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Pyrexia (fever)

50-59:

Acute myocardial infarction (acute heart attack)
Diarrhoea
Discomfort
Headache (pain in head)
Hyperglycaemia (high blood sugar)
Nausea (feeling of having an urge to vomit)
Vomiting

60+:

Blood creatinine increased
Cardiac failure
Anuria (failure of the kidneys to produce urine)
Aortic bruit (unusual sound that blood makes when it rushes past an obstruction in aortic artery)
Blood pressure decreased
Blood sodium increased
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Cerebellar infarction (impaired blood circulation to cerebellum)
Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
Diabetic nephropathy (diabetic kidney disease)

What are the existing conditions these people have? *

Type 2 Diabetes: 7 people, 28.00%
High Blood Cholesterol: 5 people, 20.00%
Urinary Tract Disorder: 2 people, 8.00%
Humoral Immune Defect (impairment of humoral immunity): 2 people, 8.00%
Abdominal Pain: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Acarbose and Atacand?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously